TELA Bio amends 2019 equity plan, increasing share limit to 10.9M

TELA Bio's board and stockholders approved Amendment No. 2 to the company's 2019 Equity Incentive Plan, raising the maximum shares available for awards and implementing stricter repricing prohibitions. The amendment enhances governance controls while expanding the equity compensation pool available to employees and directors.